Vancomycin‐intermediate Staphylococcus aureus employs CcpA‐GlmS metabolism regulatory cascade to resist vancomycin
Abstract Vancomycin (VAN)‐intermediate Staphylococcus aureus (VISA) is a critical cause of VAN treatment failure worldwide. Multiple genetic changes are reportedly associated with VISA formation, whereas VISA strains often present common phenotypes, such as reduced autolysis and thickened cell wall....
Saved in:
| Main Authors: | Huagang Peng, Yifan Rao, Weilong Shang, Yi Yang, Li Tan, Lu Liu, Zhen Hu, Yuting Wang, Xiaonan Huang, He Liu, Mengyang Li, Zuwen Guo, Juan Chen, Yuhua Yang, Jianghong Wu, Wenchang Yuan, Qiwen Hu, Xiancai Rao |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2024-12-01
|
| Series: | MedComm – Future Medicine |
| Subjects: | |
| Online Access: | https://doi.org/10.1002/mef2.70007 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
CcpA-mediated regulation of cellular energy metabolism in the ruminal bacterium Streptococcus bovis
by: Yunan Weng, et al.
Published: (2025-08-01) -
Oral vancomycin use and incidence of vancomycin-resistant enterococci: time-series analysis
by: Seongman Bae, et al.
Published: (2024-12-01) -
Surface-functionalized UIO-66-NH2 for dual-drug delivery of vancomycin and amikacin against vancomycin-resistant Staphylococcus aureus
by: Nazanin Rahmanian, et al.
Published: (2024-11-01) -
Methicillin-resistant Staphylococcus aureus with reduced vancomycin susceptibility in Taiwan
by: Chien-Yu Lin, et al.
Published: (2018-01-01) -
Inducible knockdown of Plasmodium gene expression using the glmS ribozyme.
by: Parichat Prommana, et al.
Published: (2013-01-01)